This is the authors' abstract. We don't add key points for this paper.
; if clinical laboratories do not, the burden of culturing falls to state public health laboratories, which might not be able to absorb that burden as the adoption of these tests increases (2). Strategies are needed to preserve access to bacterial isolates for further characterization and to determine the effect of changing trends in testing practices on surveillance.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Marder et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: